Mahamaya Lifesciences P/E Ratio

Current P/E Ratio
25.4
High Valuation
High - Growth expectations or overvalued

Mahamaya Lifesciences P/E ratio. Mahamaya Lifesciences (MAHALIFE) P/E ratio is 25.4 (High), EPS (TTM) ₹8.33, current price ₹ on None — High - Growth expectations or overvalued. Also explore Mahamaya Lifesciences stock price data download to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 25.4
Current Price ₹
EPS (TTM) ₹8.33
Exchange None

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 36.16
Sector Median 19.3
Sector Rank #11 of 266
Sector Percentile 4.1%

Earnings Breakdown (TTM)

TTM EPS ₹3.04
Mar 2025 ₹3.04

MAHALIFE P/E Ratio — Valuation Signal & Historical Context

Mahamaya Lifesciences P/E 25.4 — signal: Overvalued. Check MAHALIFE market capitalization to track the company's total market size over time.

  • Stock appears overvalued with PE of 25.4, suggesting caution for new investments
  • Trading at discount to sector average PE of 36.16

MAHALIFE vs Chemicals Peers — P/E Ratio Comparison

Mahamaya Lifesciences P/E 25.4 vs Chemicals average 36.16, median 19.3 — range 0.6–769.8.

Sector Average
36.16
Sector Median
19.3
Lowest P/E
0.6
Highest P/E
769.8
Companies
266
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Kiri Industries KIRIINDUS 0.6 ₹3,213 Low
Pratiksha Chemicals PRATIKSH 0.63 ₹8 Low
Kuwer Industries KUWERIN 2.5 ₹8 Low
Bhagwati Oxygen BHAGWOX 2.7 ₹8 Low
Polychem POLYCHEM 2.8 ₹73 Low
AG Ventures AGVENTURES 3.1 ₹67 Low
Shiv Texchem SHIVTEXCHEM 3.4 ₹271 Low
Mysore Petro Chemicals MYSORPETRO 4.2 ₹84 Low
Zuari Agro Chemicals ZUARI 4.7 ₹796 Low
GOCL Corporation GOCLCORP 4.7 ₹1,684 Low